Modulation of mAb quality attributes using microliter scale fed‐batch cultures
暂无分享,去创建一个
Hervé Broly | Matthieu Stettler | Yolande Rouiller | Martin Jordan | H. Broly | Matthieu Stettler | M. Jordan | Yolande Rouiller | Arnaud Périlleux | Marie-Noëlle Vesin | Arnaud Périlleux | Marie-Noëlle Vesin
[1] N. Hooper,et al. Families of zinc metalloproteases , 1994, FEBS letters.
[2] M. Hentze,et al. Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.
[3] Jean-Luc Teillaud,et al. Impact of Glycosylation on Effector Functions of Therapeutic IgG † , 2010, Pharmaceuticals.
[4] F. Gòdia,et al. Considerations on the lactate consumption by CHO cells in the presence of galactose. , 2006, Journal of biotechnology.
[5] S. Iida,et al. Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. , 2007, Molecular immunology.
[6] Hervé Broly,et al. Cell culture medium improvement by rigorous shuffling of components using media blending , 2012, Cytotechnology.
[7] M. Neville,et al. Divalent cation activation of galactosyltransferase in native mammary Golgi vesicles. , 1990, The Journal of biological chemistry.
[8] S. Iida,et al. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies , 2006, Expert opinion on biological therapy.
[9] Martin Gawlitzek,et al. Identification of cell culture conditions to control N‐glycosylation site‐occupancy of recombinant glycoproteins expressed in CHO cells , 2009, Biotechnology and bioengineering.
[10] H. Ganther,et al. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. , 1999, Carcinogenesis.
[11] Yoshiro Saito,et al. Cell Death Caused by Selenium Deficiency and Protective Effect of Antioxidants* , 2003, Journal of Biological Chemistry.
[12] Wei Wang,et al. Protein aggregation--pathways and influencing factors. , 2010, International journal of pharmaceutics.
[13] Bo Zhang,et al. Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibody. , 2010, Journal of pharmaceutical sciences.
[14] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[15] Scott Estes,et al. Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function , 2008, Biotechnology and bioengineering.
[16] Z. Li,et al. Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.
[17] Ashraf Amanullah,et al. Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures , 2010, Biotechnology and bioengineering.
[18] W. Duetz,et al. Microtiter plates as mini-bioreactors: miniaturization of fermentation methods. , 2007, Trends in microbiology.
[19] G. N. Rogers,et al. Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system , 2007, Biotechnology and bioengineering.
[20] Jun Luo,et al. Probing of C‐terminal lysine variation in a recombinant monoclonal antibody production using Chinese hamster ovary cells with chemically defined media , 2012, Biotechnology and bioengineering.
[21] Yao-ming Huang,et al. Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells , 2009, The Journal of Biological Chemistry.
[22] Ashraf Amanullah,et al. Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process , 2012, Biotechnology and bioengineering.
[23] Wai Lam W Ling,et al. Role of iron and sodium citrate in animal protein‐free CHO cell culture medium on cell growth and monoclonal antibody production , 2011, Biotechnology progress.
[24] K. Shitara,et al. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.
[25] H. E. Johansson,et al. Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells , 2013, Proceedings of the National Academy of Sciences.
[26] B. Vallee,et al. Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.
[27] V. Quarmby,et al. Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities , 2012, mAbs.
[28] X. Zhong,et al. Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications , 2013, International journal of cell biology.
[29] Akira Okazaki,et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. , 2007, Glycobiology.
[30] T. Raju,et al. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. , 2008, Current opinion in immunology.
[31] C. Kahana,et al. The Role of Polyamines in Supporting Growth of Mammalian Cells Is Mediated through Their Requirement for Translation Initiation and Elongation*♦ , 2010, The Journal of Biological Chemistry.
[32] Huub Schellekens,et al. Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.
[33] E. Stadtman,et al. Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron. , 1985, The Journal of biological chemistry.
[34] H. Broly,et al. A high-throughput media design approach for high performance mammalian fed-batch cultures , 2013, mAbs.
[35] B. Scallon,et al. Engineering host cell lines to reduce terminal sialylation of secreted antibodies , 2010, mAbs.
[36] S. Gorfien,et al. An HPLC-MALDI MS method for N-glycan analyses using smaller size samples: Application to monitor glycan modulation by medium conditions , 2009, Glycoconjugate Journal.
[37] Gary J Lye,et al. Microwell engineering characterization for mammalian cell culture process development , 2010, Biotechnology and bioengineering.
[38] Marcella Yu,et al. Effects of cell culture conditions on antibody N‐linked glycosylation—what affects high mannose 5 glycoform , 2011, Biotechnology and bioengineering.
[39] A. Ambrogelly,et al. Assessment of AMBRTM as a model for high-throughput cell culture process development strategy , 2012 .
[40] L. Presta,et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.
[41] Daniela Bumbaca,et al. Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics , 2012, The AAPS Journal.
[42] Nigel Jenkins,et al. Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals , 2008, Molecular biotechnology.
[43] Marcella Yu,et al. Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans , 2012, mAbs.
[44] K. Kashiwagi,et al. Modulation of cellular function by polyamines. , 2010, The international journal of biochemistry & cell biology.
[45] Xiaoping Z He,et al. Analysis of charge heterogeneities in mAbs using imaged CE , 2009, Electrophoresis.
[46] D. Eccles,et al. A Germ Line Mutation in the Death Domain of DAPK-1 Inactivates ERK-induced Apoptosis* , 2007, Journal of Biological Chemistry.
[47] J. Ravetch,et al. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.
[48] Michael C. Borys,et al. Identification of cell culture conditions to control protein aggregation of IgG fusion proteins expressed in Chinese hamster ovary cells , 2012 .
[49] R Thorpe,et al. Fragmentation of Therapeutic Human Immunoglobulin Preparations , 1995, Vox sanguinis.
[50] M B Sliwkowski,et al. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. , 2000, Biotechnology and bioengineering.
[51] Kai Griebenow,et al. Effects of glycosylation on the stability of protein pharmaceuticals. , 2009, Journal of pharmaceutical sciences.
[52] K. Brew,et al. Specificity and Mechanism of Metal Ion Activation in UDP-galactose:β-Galactoside-α-1,3-galactosyltransferase* , 2001, The Journal of Biological Chemistry.
[53] S L Morrison,et al. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. , 1998, Journal of immunology.
[54] Matthieu Stettler,et al. Tools for high-throughput process and medium optimization. , 2014, Methods in molecular biology.
[55] R. Ionescu,et al. Fragmentation of monoclonal antibodies , 2011, mAbs.
[56] M. Butler,et al. Effects of Ammonia and Glucosamine on the Heterogeneity of Erythropoietin Glycoforms , 2002, Biotechnology progress.
[57] Reed J. Harris,et al. Effect of Copper Sulfate on Performance of a Serum‐Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody Expressed , 2008, Biotechnology progress.
[58] Hongcheng Liu,et al. Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[59] David Pollard,et al. A review of advanced small‐scale parallel bioreactor technology for accelerated process development: Current state and future need , 2011, Biotechnology progress.
[60] M A Smith,et al. Specific cleavage of immunoglobulin G by copper ions. , 2009, International journal of peptide and protein research.
[61] R. Timpl,et al. Two non‐contiguous regions contribute to nidogen binding to a single EGF‐like motif of the laminin gamma 1 chain. , 1994, The EMBO journal.
[62] J. P. Pêgas Henriques,et al. The Influence of Micronutrients in Cell Culture: A Reflection on Viability and Genomic Stability , 2013, BioMed research international.
[63] Niki S. C. Wong,et al. An investigation of intracellular glycosylation activities in CHO cells: Effects of nucleotide sugar precursor feeding , 2010, Biotechnology and bioengineering.
[64] P. Salmon,et al. A novel function for selenium in biological system: Selenite as a highly effective iron carrier for Chinese hamster ovary cell growth and monoclonal antibody production , 2006, Biotechnology and bioengineering.
[65] R. Stevenson,et al. β-Galactosidase Gene Mutations in Patients With Slowly Progressive GM1 Gangliosidosis , 1997, Journal of child neurology.
[66] John A. Tainer,et al. Structure and mechanism of copper, zinc superoxide dismutase , 1983, Nature.
[67] Jongkyeong Chung,et al. Selenite suppresses hydrogen peroxide‐induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3‐K/Akt pathways , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] J. T. Saari,et al. Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart. , 2007, The Journal of nutrition.
[69] W. Xu,et al. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies , 2012, mAbs.
[70] Cleo Kontoravdi,et al. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns , 2010, Biotechnology progress.
[71] D. Richardson,et al. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. , 1997, Biochimica et biophysica acta.
[72] Alex Eon-Duval,et al. Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approach , 2012, Biotechnology progress.
[73] Peifeng Chen,et al. Effects of elevated ammonium on glycosylation gene expression in CHO cells. , 2006, Metabolic engineering.
[74] Michael W. Laird,et al. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing , 2010, Biotechnology and bioengineering.
[75] P. V. van Berkel,et al. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose , 2011, Biotechnology and bioengineering.
[76] S. Elliott,et al. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. , 2005, Journal of pharmaceutical sciences.
[77] Peiqing Zhang,et al. The sweet tooth of biopharmaceuticals: Importance of recombinant protein glycosylation analysis , 2012, Biotechnology journal.
[78] T. Michiels,et al. Mutations That Affect the Tropism of DA and GDVII Strains of Theiler's Virus In Vitro Influence Sialic Acid Binding and Pathogenicity , 2002, Journal of Virology.
[79] B. Imperiali,et al. Metal ion dependence of oligosaccharyl transferase: implications for catalysis. , 1995, Biochemistry.
[80] G. Marx,et al. Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. , 1986, The Biochemical journal.
[81] S. Yoon,et al. Substitution of glutamine by glutamate enhances production and galactosylation of recombinant IgG in Chinese hamster ovary cells , 2010, Applied Microbiology and Biotechnology.
[82] Paul Chen,et al. Control of misincorporation of serine for asparagine during antibody production using CHO cells , 2010, Biotechnology and bioengineering.
[83] Shujun Bai,et al. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. , 2011, Biotechnology and bioengineering.
[84] D. James,et al. Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro , 2005, Biotechnology progress.
[85] Mauricio Vergara,et al. Advances in improving mammalian cells metabolism for recombinant protein production , 2013 .
[86] K. Williams. Interactions of polyamines with ion channels. , 1997, The Biochemical journal.
[87] Nigel Jenkins,et al. Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.
[88] D. James,et al. CHO cell line specific prediction and control of recombinant monoclonal antibody N‐glycosylation , 2013, Biotechnology and bioengineering.
[89] Tom Vink,et al. N‐linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG , 2009, Biotechnology progress.
[90] Rachel Bareither,et al. Automated disposable small scale reactor for high throughput bioprocess development: A proof of concept study , 2013, Biotechnology and bioengineering.
[91] B. Scallon,et al. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. , 2007, Molecular immunology.
[92] Kiran Mukhyala,et al. Effects of charge on antibody tissue distribution and pharmacokinetics. , 2010, Bioconjugate chemistry.
[93] Amber Haynes Fradkin,et al. Immunogenicity of aggregates of recombinant human growth hormone in mouse models. , 2009, Journal of pharmaceutical sciences.
[94] F. Naider,et al. Substrate recognition by oligosaccharyltransferase. Studies on glycosylation of modified Asn-X-Thr/Ser tripeptides. , 1983, The Journal of biological chemistry.
[95] T. H. Nguyen,et al. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. , 1995, Biochemistry.
[96] Martin Gawlitzek,et al. Effect of cell culture medium components on color of formulated monoclonal antibody drug substance , 2013, Biotechnology progress.
[97] N. Seiler,et al. Polyamines and apoptosis , 2005, Journal of cellular and molecular medicine.